Search results

9 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Diabetes drug lowers risk of cardiovascular complications, kidney disease
For the first time, a large clinical trial showed across-the-board cardiovascular benefit of a diabetes drug – liraglutide – a much-needed outcome for people with type 2 diabetes.
Located in News / 2016 / June
UNC clinical trials play crucial role in FDA approval for diabetes drug
Led by John Buse, MD, PhD, director of the UNC Diabetes Care Center, the clinical research of UNC doctors and the participation of thousands of patients culminates in a new, effective, and safe daily injectable drug to combat type-2 diabetes.
Located in News / 2016 / November
Scientists create painless patch of insulin-producing beta cells to control diabetes
The new “smart cell patch” developed at UNC and NC State is a proof of principle to treat millions of people with type-1 and advanced type-2 diabetes.
Located in News / 2016 / March
UNC scientist’s drive for a cancer cure inspired by the father he doesn’t remember
Zhen Gu, a biomedical engineer at the University of North Carolina and N.C. State University, is featured in STAT News for his work on cancer.
Located in News / 2016 / August
Liquid Metal ‘Nano-Terminators’ Target Cancer Cells
The new cancer drug delivery system improved efficacy of standard chemotherapy for ovarian cancer in mice with limited toxicity.
Located in News / 2015 / December
Life-extending benefits of liver cancer drug not realistic for many patients
The drug sorafenib can have serious side effects and significant out-of-pocket costs for advanced liver cancer patients, according to a study led by UNC’s Hanna Sanoff, MD, MPH.
Located in News / 2016 / May
Microneedle patch delivers localized cancer immunotherapy to melanoma
UNC / NC State researchers devise a new nanotechnology to enhance the body’s own immune response to kill skin cancer tumors.
Located in News / 2016 / March
Duke/UNC Team Testing New Strategies to Prevent Clotting in Patients with Pancreatic Cancer
CTSA collaborative funding award supports mouse-model research. Nigel Mackman, PhD, of UNC, and Rebekah White, MD, of Duke are leading the effort.
Located in News / 2016 / June
Two UNC School of Medicine startup companies featured in Congressional event
Renovion and EpiCypher, spinouts from the work of David Henke, MD, and Brian Strahl, PhD, respectively, were celebrated this week at the National Council of Entrepreneurial Tech Transfer’s University Startups Demo Day
Located in News / 2016 / September